Marc Guieb
Consultant
San Diego, CA, US
Marc Guieb is a consultant with the San Diego office of Milliman. He joined the firm in 2018 and has been working in the pharmacy industry since 2013.
Experience
Marc has experience in the pharmacy industry working in medical writing and at a national retail pharmacy chain. He has conducted competitive surveillance for industry clients, with specialization in diabetes, obesity, and haemostasis, and staffed at a high-volume pharmacy. As a consultant for Milliman, he has worked in both Medicaid and commercial pharmacy benefits contracting and in claims auditing. Marc supports clients through his knowledge of pharmacy operations, regulations, formulary management, clinical trial evaluation, drug utilization review, and pipeline forecasting.
Professional Designations
- Member, American Pharmacists Association (APhA)
Education
- PharmD, Ernest Mario School of Pharmacy, Rutgers University
Publications
Read their latest work
Article
Pharmacy Briefing | November 2024
20 November 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the key pharmacy highlights from November , including FDA approvals and launches, and industry developments.
Article
Pharmacy Briefing | July 2024
14 August 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail key pharmacy news from July, including FDA approvals and launches and industry developments.
Article
Commercial drug trends: 2024 release
24 July 2024 - by Brian Anderson, Rebekah Bayram, Andrew Dressler, Marc Guieb, Niharika Tarimela, Jason Mui
Pharmacy benefits costs continue to rise year over year, driven by a variety of factors such as novel treatments, consumer demand, and federal legislation.
Article
Pharmacy Briefing | May 2024
17 June 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest pharmacy news, including FDA approvals and launches, and industry developments.
Article
Pharmacy Briefing | February 2024
20 February 2024 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest pharmacy news, trends, and insights, including FDA approvals and launches, clinical trials, and industry developments.
Article
Pharmacy Briefing | October 2023
22 November 2023 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest pharmacy news, trends, and insights, including FDA approvals and launches, clinical trials, and industry developments.
Article
Commercial Drug Trends: 2023 release
13 October 2023 - by Brian Anderson, Rebekah Bayram, Marc Guieb, Niharika Tarimela, Andrew Dressler
Average wholesale drug prices per member will increase 11% to 19% among commercial health plans from 2022 to 2024, according to our analysis of pharmaceutical spending trends.
Article
Pharmacy Briefing | July 2023
29 August 2023 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest pharmacy news, trends, and insights, including FDA approvals and launches, clinical trials, and industry developments.
Article
Pharmacy Briefing | May 2023
27 June 2023 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest on pharmacy news, trends, and insights, including items on the company and state levels, FDA approvals and launches, and clinical trials.
Article
Pharmacy Briefing | March 2023
24 April 2023 - by Brian Anderson, Rebekah Bayram, Marc Guieb
We detail the latest on pharmacy news, trends, and insights, including items on the company and state levels, FDA approvals and launches, and clinical trials.